Tech Company Financing Transactions
DTx Pharma Funding Round
On 1/13/2020, DTx Pharma landed $10.6 million in funding from Friedman BioVentures, ExSight Capital and Tech Coast Angels.
Transaction Overview
Company Name
Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$10,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10655 Sorrento Valley Rd. 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
At DTx we're inspired to improve the lives of patients suffering from rare and chronic diseases worldwide by introducing next-generation, safe and effective medicines based on fatty acid motifs that deliver RNA medicines to tissues and organ systems beyond the liver.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arthur Suckow
Chief Operating Officer
Denise Bevers
Chief Scientific Officer
Bryan Laffitte
Co-Founder
John Grundy
Vice President
Charles Allerson
Browse more venture capital transactions:
Prev: 1/13/2020: Practifi venture capital transaction
Next: 1/13/2020: e-Zn venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs